Allergy immunotherapy - Roxall Medizin
Alternative Names: Allergovac depot Olea; Allergovac grass pollen; Allergovac grass pollen depot; Allergovac Poliplus; BIA 14-2964; Olea europaea extract - Bial; PHLEUM PRATENSE POLLEN; SULGEN Spray Dermatophagoides pteronyssinus; SULGEN Spray Phleum pratenseLatest Information Update: 06 Jun 2024
Price :
$50 *
At a glance
- Originator Bial
- Developer BIAL; ROXALL Medizin GmbH
- Class Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Allergic rhinoconjunctivitis
- Phase II Seasonal allergic rhinitis
Most Recent Events
- 09 Feb 2024 Roxall Medizin GmbH completes a phase II trial in Seasonal allergic rhinitis (In adults) in Germany (Sublingual) (EudraCT2021-002881-42)
- 09 Feb 2024 Roxall Medizin GmbH completes a phase II trial in Allergic rhinoconjunctivitis (In adults) in Germany (Sublingual) (EudraCT2021-002881-42)
- 16 Mar 2023 Phase-II/III clinical trials in Allergic rhinoconjunctivitis (In adults) in Germany (Sublingual) (EudraCT2021-005169-41)